Stanley Frankel
Direttore/Membro del Consiglio presso PRECISION BIOSCIENCES, INC.
Patrimonio netto: 41 329 $ in data 30/04/2024
Relazioni attive
| Nome | Sesso | Età | Società collegate | Collaborazione |
|---|---|---|---|---|
| David Elkins | M | 55 | 6 anni | |
| Gilles Seydoux | M | - |
Cytovia Therapeutics, Inc.
 Cytovia Therapeutics, Inc. BiotechnologyHealth Technology Cytovia Therapeutics, Inc. engages in transformational immunotherapies for cancer and severe acute infectious diseases. Its products include Multi-Specific NK Engager Antibodies and iPSC CAR NK cells. The company was founded by Daniel Teper, Gilles Seydoux, and Massimo Radaelli and is headquartered in New York, NY. | - |
| Daniel Getts | M | - |
Myeloid Therapeutics, Inc.
 Myeloid Therapeutics, Inc. BiotechnologyHealth Technology Myeloid Therapeutics, Inc. operates as an immuno-oncology company that engages in the development of cell program to cure cancer. It offers ATAK platform, a cell therapy technology. The company was founded by Ronald Vale, Siddhartha Mukherjee, Daniel Getts, and Thomas Cahill in 2019 and is headquartered in Cambridge, MA. | 5 anni |
| Julia Haller | M | 69 | 5 anni | |
| John Kelly | M | 57 | 4 anni | |
| Daniel Teper | M | 64 |
Cytovia Therapeutics, Inc.
Cytovia Therapeutics, Inc. BiotechnologyHealth Technology Cytovia Therapeutics, Inc. engages in transformational immunotherapies for cancer and severe acute infectious diseases. Its products include Multi-Specific NK Engager Antibodies and iPSC CAR NK cells. The company was founded by Daniel Teper, Gilles Seydoux, and Massimo Radaelli and is headquartered in New York, NY. | - |
| Kevin Buehler | M | 66 | 5 anni | |
| Michael Amoroso | M | 46 | 3 anni | |
| Thomas Cahill | M | 37 |
Myeloid Therapeutics, Inc.
Myeloid Therapeutics, Inc. BiotechnologyHealth Technology Myeloid Therapeutics, Inc. operates as an immuno-oncology company that engages in the development of cell program to cure cancer. It offers ATAK platform, a cell therapy technology. The company was founded by Ronald Vale, Siddhartha Mukherjee, Daniel Getts, and Thomas Cahill in 2019 and is headquartered in Cambridge, MA. | 5 anni |
| Jeff Smith | M | - | 18 anni | |
| Mei Burris | F | - | 5 anni | |
| Melinda Brown | F | 67 | 2 anni | |
| Dario Scimeca | M | 49 | 5 anni | |
| Robert Plenge | M | 53 | 5 anni | |
| Samuel Wadsworth | M | 75 | 3 anni | |
| Sinu Bhandaru | M | - | 7 anni | |
| Anna Baran-Djokovic | F | - |
Cytovia Therapeutics, Inc.
Cytovia Therapeutics, Inc. BiotechnologyHealth Technology Cytovia Therapeutics, Inc. engages in transformational immunotherapies for cancer and severe acute infectious diseases. Its products include Multi-Specific NK Engager Antibodies and iPSC CAR NK cells. The company was founded by Daniel Teper, Gilles Seydoux, and Massimo Radaelli and is headquartered in New York, NY. | - |
| Armin V. Rath | M | - |
Cytovia Therapeutics, Inc.
Cytovia Therapeutics, Inc. BiotechnologyHealth Technology Cytovia Therapeutics, Inc. engages in transformational immunotherapies for cancer and severe acute infectious diseases. Its products include Multi-Specific NK Engager Antibodies and iPSC CAR NK cells. The company was founded by Daniel Teper, Gilles Seydoux, and Massimo Radaelli and is headquartered in New York, NY. | - |
| Shari Lisa Piré | F | 59 | 3 anni | |
| Phyllis Yale | F | 66 | 5 anni | |
| Mark Rolfe | M | - | 5 anni | |
| Laurent Audoly | M | - |
Cytovia Therapeutics, Inc.
Cytovia Therapeutics, Inc. BiotechnologyHealth Technology Cytovia Therapeutics, Inc. engages in transformational immunotherapies for cancer and severe acute infectious diseases. Its products include Multi-Specific NK Engager Antibodies and iPSC CAR NK cells. The company was founded by Daniel Teper, Gilles Seydoux, and Massimo Radaelli and is headquartered in New York, NY. | - |
| Derica Rice | M | 59 | 4 anni | |
| Geno Germano | M | 63 | 4 anni | |
| Michael Friedman | M | 80 |
Cytovia Therapeutics, Inc.
Cytovia Therapeutics, Inc. BiotechnologyHealth Technology Cytovia Therapeutics, Inc. engages in transformational immunotherapies for cancer and severe acute infectious diseases. Its products include Multi-Specific NK Engager Antibodies and iPSC CAR NK cells. The company was founded by Daniel Teper, Gilles Seydoux, and Massimo Radaelli and is headquartered in New York, NY. | - |
| Paula Price | F | 62 | 4 anni | |
| Ann Li Lee | M | 63 | 6 anni | |
| Kaouthar Lbiati | M | 45 |
Cytovia Therapeutics, Inc.
Cytovia Therapeutics, Inc. BiotechnologyHealth Technology Cytovia Therapeutics, Inc. engages in transformational immunotherapies for cancer and severe acute infectious diseases. Its products include Multi-Specific NK Engager Antibodies and iPSC CAR NK cells. The company was founded by Daniel Teper, Gilles Seydoux, and Massimo Radaelli and is headquartered in New York, NY. | - |
| Juli Blanche | F | - | 2 anni | |
| Olivier Gouédard | M | - |
Cytovia Therapeutics, Inc.
Cytovia Therapeutics, Inc. BiotechnologyHealth Technology Cytovia Therapeutics, Inc. engages in transformational immunotherapies for cancer and severe acute infectious diseases. Its products include Multi-Specific NK Engager Antibodies and iPSC CAR NK cells. The company was founded by Daniel Teper, Gilles Seydoux, and Massimo Radaelli and is headquartered in New York, NY. | 3 anni |
| Alan List | M | 69 | 3 anni | |
| Daniel Geffken | M | 67 |
Myeloid Therapeutics, Inc.
Myeloid Therapeutics, Inc. BiotechnologyHealth Technology Myeloid Therapeutics, Inc. operates as an immuno-oncology company that engages in the development of cell program to cure cancer. It offers ATAK platform, a cell therapy technology. The company was founded by Ronald Vale, Siddhartha Mukherjee, Daniel Getts, and Thomas Cahill in 2019 and is headquartered in Cambridge, MA. | - |
| Cindy Atwell | F | - | 5 anni | |
| Thomas H. Robinson | M | 65 |
Cytovia Therapeutics, Inc.
Cytovia Therapeutics, Inc. BiotechnologyHealth Technology Cytovia Therapeutics, Inc. engages in transformational immunotherapies for cancer and severe acute infectious diseases. Its products include Multi-Specific NK Engager Antibodies and iPSC CAR NK cells. The company was founded by Daniel Teper, Gilles Seydoux, and Massimo Radaelli and is headquartered in New York, NY. | - |
| Elaine Jones | M | 69 |
Myeloid Therapeutics, Inc.
Myeloid Therapeutics, Inc. BiotechnologyHealth Technology Myeloid Therapeutics, Inc. operates as an immuno-oncology company that engages in the development of cell program to cure cancer. It offers ATAK platform, a cell therapy technology. The company was founded by Ronald Vale, Siddhartha Mukherjee, Daniel Getts, and Thomas Cahill in 2019 and is headquartered in Cambridge, MA. | 3 anni |
| Brett Ilan Kaplan | M | 50 |
Myeloid Therapeutics, Inc.
Myeloid Therapeutics, Inc. BiotechnologyHealth Technology Myeloid Therapeutics, Inc. operates as an immuno-oncology company that engages in the development of cell program to cure cancer. It offers ATAK platform, a cell therapy technology. The company was founded by Ronald Vale, Siddhartha Mukherjee, Daniel Getts, and Thomas Cahill in 2019 and is headquartered in Cambridge, MA. | 2 anni |
| Teresa Foy | M | 60 | 5 anni | |
| Neil Leatherbury | M | - | 7 anni | |
| Jason Aryeh | M | 55 |
Cytovia Therapeutics, Inc.
Cytovia Therapeutics, Inc. BiotechnologyHealth Technology Cytovia Therapeutics, Inc. engages in transformational immunotherapies for cancer and severe acute infectious diseases. Its products include Multi-Specific NK Engager Antibodies and iPSC CAR NK cells. The company was founded by Daniel Teper, Gilles Seydoux, and Massimo Radaelli and is headquartered in New York, NY. | 3 anni |
Grafico relazionale
Relazione in diverse aziende
Relazioni precedenti
| Nome | Sesso | Età | Società collegate | Collaborazione |
|---|---|---|---|---|
| Jacqualyn Fouse | M | 62 | 7 anni | |
| Robert Hugin | M | 69 | 19 anni | |
| Matthew Kane | M | 47 | 15 anni | |
| Jonathan Biller | M | 61 | 8 anni | |
| Michael Bonney | M | 65 | 6 anni | |
| Peter Kellogg | M | 67 | 5 anni | |
| Scott Smith | M | 61 | 10 anni | |
| Thomas Daniel | M | 70 | 10 anni | |
| Timothy J. Smith | M | - | - | |
| Brendan Delaney | M | 49 | 6 anni | |
| Thomas Perone | M | 59 | 12 anni | |
| Jay Backstrom | M | 69 | 11 anni | |
| Ann Lee | M | 62 | 3 anni | |
| Nadim Ahmed | M | 56 | 11 anni | |
| Gerald F. Masoudi | M | 56 | 3 anni | |
| David Thomson | M | 63 | 4 anni | |
| Fouad Namouni | M | 55 | 21 anni | |
| Jill Andersen | F | 51 | 4 anni | |
| Jacquelyn Sumer | F | 46 | 1 anni | |
| Robert Hershberg | M | 61 | 5 anni | |
| Charles Bancroft | M | 65 | 36 anni | |
| Rupert Vessey | M | 59 | 4 anni | |
| Carrie Cox | F | 66 | 10 anni | |
| Alan J. Lacy | M | 70 | 12 anni | |
| Patricia Hemingway Hall | F | 71 | 1 anni | |
| Michael Grobstein | M | 81 | 13 anni | |
| Bruce McCreedy | M | 64 |
Myeloid Therapeutics, Inc.
Myeloid Therapeutics, Inc. BiotechnologyHealth Technology Myeloid Therapeutics, Inc. operates as an immuno-oncology company that engages in the development of cell program to cure cancer. It offers ATAK platform, a cell therapy technology. The company was founded by Ronald Vale, Siddhartha Mukherjee, Daniel Getts, and Thomas Cahill in 2019 and is headquartered in Cambridge, MA. | 5 anni |
| Tony Yao | M | 51 | 3 anni | |
| John Weiland | M | 68 | 1 anni | |
| Raymond Schinazi | M | 74 | 3 anni | |
| Richard Morgan | M | 79 | 29 anni | |
| Gilla Kaplan | M | 76 | 20 anni | |
| Kristen Hege | M | 60 | 9 anni | |
| Shalini Sharp | F | 49 | 4 anni | |
| John E. Elicker | M | 64 | 20 anni | |
| Lawrence V. Stein | M | 74 | 3 anni | |
| Anthony P Waclawski | M | 62 | 6 anni | |
| Tamar Thompson | F | 50 | 4 anni | |
| Deanna Weber | F | - | - | |
| Daniel O’Connell | M | 44 | - | |
| JC Xu | M | 60 | 3 anni | |
| Samuel Moed | M | 62 | 32 anni | |
| Sotirios G. Stergiopoulos | M | 52 | 2 anni | |
| Vicki Goodman | M | 55 | 5 anni | |
| Joe Hand | M | - | 2 anni | |
| Jerome Zeldis | M | 74 | 19 anni | |
| Paul D'Angio | M | 65 | 18 anni | |
| Philippe Martin | M | - | 7 anni | |
| Aditya Ash Damle | M | - | 2 anni | |
| Matt Roden | M | 53 | 4 anni | |
| Randall M. Stevens | M | - | - | |
| Gregory Oakes | M | 56 | 2 anni | |
| Rajesh Chopra | M | 63 | 7 anni | |
| Maureen T. Cronin | M | 70 | 5 anni | |
| Jean Bizzari | M | 69 | 7 anni | |
| Kathryn Metcalfe | F | - | - | |
| Hans Bishop | M | 59 | 1 anni | |
| Neil Desai | M | 59 | 6 anni | |
| George Golumbeski | M | 67 | 9 anni | |
| Edward Atkinson | M | 58 | 8 anni |
Statistiche
| Paese | Relazioni | % del totale |
|---|---|---|
| Stati Uniti | 99 | 100.00% |
Età delle relazioni
Attive
Scorse
Uomo
Donna
Amministratori
Dirigenti
Provenienza delle relazioni
- Borsa valori
- Insiders
- Stanley Frankel
- Contatti personali
